PRKN and Parkinson disease: In PD, reduced mitochondrial Complex I activity in the substantia nigra is accompanied by genetic defects (PINK1, PARKIN, DJ-1) and mitochondrial-targeting toxins (e.g., rotenone, MPTP) [54,55].